Close Menu

Lung Cancer

News and reporting on lung cancer.

The company will be using the funds to develop and test a prototype of the diagnostic, which it hopes to bring to market sometime in 2011, said a company official.

Roche presents data from HPV Dx trial; Epigenomics launches Epi proLung BL Reflex Assay in Europe.

A company official said that VeriStrat sales are growing at a double-digit pace and that Biodesix is also looking to apply the test to diseases beyond lung cancer.

Epigenomics' PCR-based lung cancer reflex diagnostic test has been validated in a key clinical trial, clearing the way for the test to receive the CE Mark for in vitro diagnostics and for the company to launch the test in Europe in coming weeks.

Proteomics research papers of note, June 2010

The company said that the placing was intended to raise money for capital investment in equipment for its PS Biomarker Services division and to finance the further development of tandem mass tag-SRM mass spectrometry assays for its proprietary biomarkers.

The firm claims the test can detect cancers as much as five years earlier than current testing methods.

The companies are developing an EGFR mutant-selective inhibitor with a companion diagnostic that will select NSCLC patients with an EGFR mutation linked to resistance to drugs like Iressa and Tarceva.

In addition to several PGx studies presented at the conference, the International Association for the Study of Lung Cancer and the European Thoracic Oncology Platform's European EGFR Workshop Group proposed recommendations on EGFR mutation testing in NSCLC when patients are treated with AstraZeneca's Iressa.

Preparing for commercialization of its LungExpress Dx test, the company boosted R&D spending and trimmed general costs.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.